Xeris Biopharma Holdings, Inc.

Empirical Financial Services, LLC d.b.a. Empirical Wealth Management XERS

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/16/2026

Shares

16,070

Value ($000)

126

Weight

0.0%

2023 Q2 - 2025 Q4 (11 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/16/2026	126	0.0%	16,070	12/31/2025
2025 Q3	11/10/2025	111	0.0%	13,650	9/30/2025
2025 Q2	7/21/2025	64	0.0%	13,650	6/30/2025
2025 Q1	5/8/2025	75	0.0%	13,650	3/31/2025
2024 Q4	1/22/2025	46	0.0%	13,650	12/31/2024
2024 Q3	11/1/2024	39	0.0%	13,650	9/30/2024
2024 Q2	8/9/2024	31	0.0%	13,650	6/30/2024
2024 Q1	5/7/2024	30	0.0%	13,650	3/31/2024
2023 Q4	2/6/2024	32	0.0%	13,650	12/31/2023
2023 Q3	11/3/2023	25	0.0%	13,650	9/30/2023
2023 Q2	8/11/2023	36	0.0%	13,650	6/30/2023